Christa Pike Has Rare Blood Cancer: Lawyers Warned of Execution Risks Months Before Botched Lethal Injection

A disturbing new development has emerged in the case of Christa Pike, the Tennessee death row inmate who survived a botched execution attempt earlier this year. Newly highlighted court documents reveal that her attorneys had warned officials months before the scheduled execution that a potentially serious blood disorder could make the lethal injection especially painful and dangerous. Despite those warnings, the execution went ahead on September 30, 2026, and ended with Pike being rushed to the hospital after surviving two doses of the drugs intended to kill her.

According to a January 2026 court filing, Pike’s lawyers raised concerns about a significantly elevated platelet count, a condition known as thrombocytosis. They said the abnormal blood results were likely linked to myeloproliferative disorder, a rare form of blood cancer that affects the production of blood cells. Her attorneys argued that the condition could increase the risk of serious complications during a lethal injection, including pulmonary edema, a potentially life-threatening buildup of fluid in the lungs that can cause severe breathing difficulties. However, the publicly reported filing does not establish that Pike has received a definitive diagnosis of this cancer.

Her medical concerns reportedly went beyond the blood disorder. The legal filing also described Pike as having small veins and a history of difficult blood draws and needle insertions. Her lawyers warned that prison medical personnel could struggle to establish an intravenous line, potentially exposing her to additional pain and complications. They even recommended using butterfly needles, which they said could reduce the difficulty and discomfort associated with accessing her veins. The attorneys also challenged Tennessee’s execution procedures, arguing that the protocol did not guarantee immediate telephone access to legal counsel if something went wrong during the process.

Those warnings became particularly significant on September 30, when Tennessee attempted to execute Pike at Riverbend Maximum Security Institution in Nashville. According to accounts provided by her attorneys, execution personnel struggled for an extended period to establish working IV lines, reportedly using numerous needles. Two doses of pentobarbital were administered, but Pike did not die. Instead, she became critically ill and was transported to a hospital. Her lawyers later described severe injuries to her arms, significant swelling and other medical complications. She remained hospitalized for approximately 10 days before being transferred back to prison.

Pike’s case has since raised serious questions about the reliability and humanity of Tennessee’s execution procedures. Governor Bill Lee suspended the state’s remaining scheduled executions for 2026 and ordered an independent investigation into what happened. Her attorneys have also challenged her continued confinement in a restrictive prison medical setting and are seeking changes to her conditions. Pike has reportedly spent much of her time isolated since returning from the hospital, while her legal team continues to raise concerns about her recovery and treatment.

Pike was sentenced to death for the 1995 murder of 19-year-old Colleen Slemmer, a fellow student at a Job Corps center in Knoxville. Pike was 18 at the time of the killing. Prosecutors said she and her boyfriend tortured and murdered Slemmer following a dispute involving their relationship. More than three decades later, Pike’s case has entered an extraordinary new chapter: she remains on death row, but the state’s failed attempt to carry out her sentence has sparked renewed legal challenges and public scrutiny. Whether Tennessee will attempt another execution remains uncertain as the investigation and court proceedings continue.

Source: https://people.com/christa-pike-has-rare-cancer-lawyers-warned-risks-botched-execution-12227198